The British and Irish orthoptic journal · 2026
Symptoms of Depression and Anxiety among Myopes: A Systematic Review and Meta-Analysis.
СтатьяОбзорНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Kyei Samuel, Asiamah Randy, Owusu Gideon, Ampiah Emmanuel Ekow
Аннотация
OBJECTIVES: To assess the prevalence of symptoms of depression and anxiety, as well as associated factors in myopes.
METHODS: Relevant studies were sourced from PubMed, Scopus, and Web of Science. A meta-analysis was conducted to determine the prevalence of symptoms of depression and anxiety in myopes. Odds ratios (OR) with corresponding 95% confidence intervals (CI) were used to compare psychological symptoms between myopic and emmetropic groups.
RESULTS: A total of six studies assessing the symptoms of depression and anxiety in myopes were included. Prevalence of symptoms of depression and anxiety in myopes are 22.99% (95% CI 16.81% to 30.61%; I 2 = 96.6%) and 26.81% (95% CI 15.62% to 42.01%; I 2 = 98.4%), respectively. Myopes are approximately 46% more likely to suffer from symptoms of depression [OR: 1.46 (95% CI 0.98 to 2.19), I 2 = 72.4%] and are 65% more likely to suffer from symptoms of anxiety [OR: 1.65 (95% CI 1.10 to 2.49), I 2 = 70.4%], as compared to emmetropes. Myopes aged less than 40 years are about 12% more likely to suffer from symptoms of depression [OR: 1.12 (95% CI 0.83 to 1.50), I 2 = 1.5%] and 26% more likely to suffer from symptoms of anxiety [OR: 1.26 (95% CI 1.11 to 1.43), I 2 = 72.5%] than age-matched emmetropes. Myopes aged 40 years and older are almost twice as likely to suffer from symptoms of depression than age-matched emmetropes [OR: 2.02 (95% CI 1.61 to 2.51), I 2 = 0.0%].
CONCLUSION: Integrated eye care approaches are advocated for and should consider the psychological impact of visual impairment. As myopia prevalence rises globally, understanding and mitigating its mental health effects will be crucial for public health.
METHODS: Relevant studies were sourced from PubMed, Scopus, and Web of Science. A meta-analysis was conducted to determine the prevalence of symptoms of depression and anxiety in myopes. Odds ratios (OR) with corresponding 95% confidence intervals (CI) were used to compare psychological symptoms between myopic and emmetropic groups.
RESULTS: A total of six studies assessing the symptoms of depression and anxiety in myopes were included. Prevalence of symptoms of depression and anxiety in myopes are 22.99% (95% CI 16.81% to 30.61%; I 2 = 96.6%) and 26.81% (95% CI 15.62% to 42.01%; I 2 = 98.4%), respectively. Myopes are approximately 46% more likely to suffer from symptoms of depression [OR: 1.46 (95% CI 0.98 to 2.19), I 2 = 72.4%] and are 65% more likely to suffer from symptoms of anxiety [OR: 1.65 (95% CI 1.10 to 2.49), I 2 = 70.4%], as compared to emmetropes. Myopes aged less than 40 years are about 12% more likely to suffer from symptoms of depression [OR: 1.12 (95% CI 0.83 to 1.50), I 2 = 1.5%] and 26% more likely to suffer from symptoms of anxiety [OR: 1.26 (95% CI 1.11 to 1.43), I 2 = 72.5%] than age-matched emmetropes. Myopes aged 40 years and older are almost twice as likely to suffer from symptoms of depression than age-matched emmetropes [OR: 2.02 (95% CI 1.61 to 2.51), I 2 = 0.0%].
CONCLUSION: Integrated eye care approaches are advocated for and should consider the psychological impact of visual impairment. As myopia prevalence rises globally, understanding and mitigating its mental health effects will be crucial for public health.